Medication info
Omecal 625 mg (Amoxicillin Trihydrate · Clavulanate Potassium (4:1))

Omecal 625 mg (Amoxicillin Trihydrate · Clavulanate Potassium (4:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
This medication is a white or almost white oval film-coated tablet.
Packaging
40 tablets (4 tablets/PTP packaging x 10)
Approval status
Active

MFDS item code 201310797 · Approved 2013.12.20 · Insurance code 671704110

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dosage of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. Creatinine clearance Dosage and administration 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)
Child dose
○ Adults and children 12 years of age or older or weighing 40 kg or more: Administer amoxicillin/clavulanate potassium orally at a dose of 250 mg/125 mg 3 times daily, every 8 hours. For severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/clavulanate potassium per dose. - Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic inflammatory disease
View approved original text

This medication is used effectively for various bacterial infections. It helps treat respiratory infections such as acute and chronic bronchitis, lobar pneumonia, empyema, and lung abscess. It can also be applied to urinary infections such as cystitis, urethritis, and pyelonephritis. It is also utilized for treating sexually transmitted infections such as pelvic inflammatory disease and gonorrhea, as well as boils, abscesses, soft tissue infections, and wound infections. It is effective for osteomyelitis and dental infections, making it applicable in a wide range of infectious situations. It is used to treat various bacterial infections to improve the patient's condition.

How to take

Adult dose

The dosage of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. Creatinine clearance Dosage and administration 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)

Child dose

○ Adults and children 12 years of age or older or weighing 40 kg or more: Administer amoxicillin/clavulanate potassium orally at a dose of 250 mg/125 mg 3 times daily, every 8 hours. For severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/clavulanate potassium per dose. - Children: Reduce the dose in the same manner.

Precautions

This medication is a beta-lactam antibiotic and should not be administered to patients with an allergy to penicillin or cephalosporin drugs or those who have experienced hypersensitivity. Caution is required particularly for patients with viral infections such as infectious mononucleosis or lymphocytic leukemia, as there is a risk of rash. Patients with liver function issues or a history of liver dysfunction or jaundice due to this medication or penicillin should avoid or use it with caution. Patients with impaired liver function should be careful as the drug may not be properly metabolized in the liver, potentially worsening their condition. Patients with moderate to severe renal impairment should adjust the dosing interval due to the increased risk of side effects as the drug stays in the body longer. Patients with allergic predispositions or family history, those unable to take orally, the elderly, and those in poor condition should be cautious of bleeding risks due to vitamin K deficiency. Patients with gastrointestinal disorders experiencing vomiting or diarrhea may not absorb the medication properly. This medication may cause gastrointestinal side effects such as diarrhea, vomiting, and abdominal pain, and in severe cases, serious enteritis such as pseudomembranous colitis can occur, requiring immediate cessation of the medication if symptoms arise. Liver function tests may show elevated levels of AST, ALT, etc., and in rare cases, hepatitis or jaundice can occur, so regular liver function testing is necessary for long-term use. Skin rash, itching, serious allergic reactions such as Stevens-Johnson syndrome or anaphylactic shock may occur rarely. Blood tests may reveal abnormalities in the blood system such as leukopenia, thrombocytopenia, or anemia, so any abnormal symptoms should prompt immediate consultation with healthcare professionals. Central nervous system abnormalities may lead to agitation, anxiety, dizziness, and rarely seizures, thus caution is especially needed for patients with impaired renal function or those receiving high doses. There may be a risk of deterioration in renal function or acute kidney failure, hence regular monitoring of kidney function is recommended. There may be a tendency towards bleeding due to vitamin K deficiency, so any bleeding symptoms should be reported immediately. Use should be avoided during pregnancy, especially in the first trimester, and pregnant or breastfeeding women should carefully consider the risks and benefits of administering this medication. This medication may interact with other drugs, particularly anticoagulants, probenecid, allopurinol, and antibiotics, requiring caution when used in combination. In cases of overdose, gastrointestinal symptoms, central nervous system symptoms, or allergic reactions may be present, necessitating immediate notification to healthcare professionals if symptoms occur.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 74 more
  • abdominal pain
  • abdominal distension
  • constipation
  • colon pain
  • hyperacidity
  • loose stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • bloody stools
  • itching
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • vesiculobullous dermatitis
  • acute generalized pustular dermatitis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • laryngeal edema
  • anaphylactic shock
  • reversible leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphocytopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • burning
  • increased secretion
  • agitation
  • anxiety
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • seizures
  • antispasmodic
  • fever
  • clouding of consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • vitamin K deficiency symptoms
  • vitamin B deficiency symptoms
  • linear IgA disease
  • taste disturbance
  • fatigue
  • dermatitis
  • oral edema
  • stomach pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial cerebral seizures
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent moisture ingress and should be kept at a cool temperature between 1 and 25 degrees Celsius. Proper storage helps maintain the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

This medication is a white or almost white oval film-coated tablet.

Package unit

40 tablets (4 tablets/PTP packaging x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.